BNTX - BioNTech SE
103.8
3.040 2.929%
Share volume: 720,655
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$100.76
3.04
0.03%
View ratios
| Fiscal Date | 03-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q1 2024 | |
| Report Date | 05-06-2024 | |
| Total revenue | 202.610 M | |
| Cost of revenue | 63.829 M | |
| Gross profit | 138.781 M | |
| Operating expenses | 691.315 M | |
| Selling general and admin | 143.209 M | |
| Research and development | 548.105 M | |
| Total expenses | 755.143 M | |
| Operating income | -552.533 M | |
| Ebit | -552.533 M | |
| Pretax income | -358.347 M | |
| Income tax | -18.036 M | |
| Net income basic | -340.311 M | |
| Net income | -340.311 M | |